Picture of Diamyd Medical AB logo

DMYD B Diamyd Medical AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Diamyd Medical's Remygen® Trial Results Get Timeline Revision

April 20 (Reuters) - Diamyd Medical AB  DMYDb.ST :
    * MINOR TIMELINE REVISION FOR REMYGEN® TRIAL TOPLINE RESULTS
    * TOPLINE RESULTS FROM UPPSALA UNIVERSITY HOSPITAL'S
REGENERATE-1
TRIAL ARE EXPECTED IN FIRST HALF OF MAY 2023
    * REVISION REFLECTS A SMALL REVISION TO ACCOMMODATE
ADDITIONAL
TIME REQUIRED FOR COMPLETING STATISTICAL ANALYSES

Source text for Eikon:  ID:nWkr3JLL6n 
Further company coverage:  DMYDb.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on Diamyd Medical AB

See all news